According to @ai_darpa, Neuralink is set to begin high-volume production of its brain-computer interface (BCI) implants in 2026, following a $650 million funding round and successful trials with over 20 patients controlling devices by thought (source: @ai_darpa, Jan 1, 2026). Elon Musk revealed that the company will use automated surgeries, with flexible threads directly piercing the dura mater, eliminating the need for removal. This breakthrough in BCI technology signals widespread adoption for practical medical applications, especially for spinal injury rehabilitation and other neurological conditions. The scalable manufacturing and surgical automation open significant business opportunities in the neurotechnology and healthcare markets, accelerating mainstream adoption of AI-powered neural interfaces.